Kaleswari Somasundaram

Ms. Kaleswari Somasundaram

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2024 in JMIR Human Factors
Verified
Journal Article
Open access
CMCaroline McBride
Caroline McBride
BHBarbara Hunter
Barbara Hunter
NLNatalie Lumsden
Natalie Lumsden
KSKaleswari Somasundaram
Kaleswari Somasundaram
RMRita McMorrow
Rita McMorrow
JMJo-Anne Manski-Nankervis
Jo-Anne Manski-Nankervis
Background: Future Health Today (FHT) is a technology program that integrates with general practice clinical software to provide point of care (PoC) clinical decision support and a quality improvement dashboard. This qualitative study looks at the use of FHT in the context of cardiovascular disease risk in chronic kidney disease (CKD). Objective: This study aims to explore factors influencing clinical implementation of the FHT module focusing on cardiovascular risk in CKD, from the perspectives of participating general practitioner staff. Methods: Practices in Victoria were recruited to participate in a pragmatic cluster randomized controlled trial using FHT, of which 19 practices were randomly assigned to use FHT’s cardiovascular risk in CKD program. A total of 13 semistructured interviews were undertaken with a nominated general practitioner (n=7) or practice nurse (n=6) from 10 participating practices. Interview questions focused on the clinical usefulness of the tool and its place in clinical workflows. Qualitative data were coded by 2 researchers and analyzed using framework analysis and Clinical Performance Feedback Intervention Theory. Results: All 13 interviewees had used the FHT PoC tool, and feedback was largely positive. Overall, clinicians described engaging with the tool as a “prompt” or “reminder” system. Themes reflected that the tool’s goals and clinical content were aligned with clinician’s existing priorities and knowledge, and the tool’s design facilitated easy integration into existing workflows. The main barrier to implementation identified by 2 clinicians was notification fatigue. A total of 7 interviewees had used the FHT dashboard tool. The main barriers to use were its limited integration into clinical workflows, such that some participants did not know of its existence; clinicians’ competing clinical priorities; and limited time to learn and use the tool. Conclusions: This study identified many facilitators for the successful use of the FHT PoC program, in the context of cardiovascular risk in CKD, and barriers to the use of the dashboard program. This work will be used to inform the wider implementation of FHT, as well as the development of future modules of FHT for other risk or disease states.

6 February 2026 in JMIR Formative Research
Verified
Journal Article
Open access
JGJaviera Martinez Gutierrez
Javiera Martinez Gutierrez
KSKaleswari Somasundaram
Kaleswari Somasundaram
CBChristina Maresch Bernardes
Christina Maresch Bernardes
MRMeena Rafiq
Meena Rafiq
SSSilja Schrader
Silja Schrader
JEJon Emery
Jon Emery
Background: Early detection in primary care could improve pancreatic cancer survival, but diagnosis is often delayed due to the low prevalence of the disease, the nonspecific nature of early symptoms, and the broad range of conditions and volume of consultations managed by general practitioners (GPs). In Australia, improving pancreatic cancer outcomes, including via earlier diagnosis, is a priority being progressed under the National Pancreatic Cancer Roadmap developed by Cancer Australia. Computerized clinical decision support systems (CDSSs) have shown promise in aiding timely cancer diagnosis; however, barriers to adopting CDSS such as mistrust of the recommendations or not being embedded in the clinical workflow remain. Simulation techniques, which offer flexible and cost-effective ways to evaluate digital health interventions, can be used to test CDSS before real-world implementation. Objective: This study aims to assess the acceptability and feasibility of identifying patients with symptoms associated with pancreatic cancer through a CDSS within a simulated environment. Methods: We developed a CDSS that interacted with an electronic health record used in general practice to identify patients with symptoms, which may indicate pancreatic cancer (unintended weight loss or new-onset diabetes), in a simulation laboratory for digital interventions. We tested it by inviting GPs (n=11) to use the CDSS, with patient actors simulating specific clinical scenarios. We then interviewed GPs about the interaction to assess the acceptability and feasibility of the CDSS in their clinical practice. We used thematic analysis and 2 relevant frameworks to analyze the data. Results: GPs found the CDSS easy to use, unobstructive, and effective as a prompt to consider investigations for people with risk factors for pancreatic cancer. However, they expressed concerns about possible overtesting, financial costs, and the potential for anxiety in patients with a very low probability of having cancer. Conclusions: While GPs found the tool useful and compatible with their workflow, concerns about overtesting, lack of evidence, and cost-effectiveness were identified as barriers. GPs favored a stepwise approach to investigations rather than immediate imaging. Despite the overall acceptability of the tool, additional evidence to underpin clinical recommendations is necessary before implementing a CDSS with these specific recommendations for pancreatic cancer in primary care.

12 June 2025 in JMIR Cancer
Verified
Journal Article
Open access
SCSophie Chima
Sophie Chima
BHBarbara Hunter
Barbara Hunter
JGJaviera Martinez Gutierrez
Javiera Martinez Gutierrez
NLNatalie Lumsden
Natalie Lumsden
CNCraig Nelson
Craig Nelson
JEJon Emery
Jon Emery
Background: For patients with cancer, the pathway to diagnosis will most often begin in general practice. In the absence of strong diagnostic features or in patients with nonspecific symptoms, delays in diagnosis can occur. Initial presentations and routine blood tests are important in determining whether a patient requires further investigation. Quality improvement interventions, including auditing tools and clinical decision support (CDS), have been developed for use in general practice to support this diagnostic process. We conducted a process evaluation of a pragmatic, cluster-randomized trial that evaluated the effectiveness of a new technology, Future Health Today (FHT), implemented in general practice to assist with the appropriate follow-up of patients at risk of undiagnosed cancer. Objectives: This study aims to understand implementation gaps, explore differences between the general practices involved, provide context to the trial effectiveness outcomes, and understand the mechanisms behind the intervention successes and failures. Methods: The trial intervention consisted of the FHT tool (with CDS, audit, recall, and quality improvement components), training and educational sessions, benchmarking reports, and ongoing practice support. The 21 general practices in the intervention arm of the trial were included in the process evaluation. Process data were collected using semistructured interviews, usability and educational session surveys, engagement with intervention components, and technical logs. The Medical Research Council’s Framework for Developing and Evaluating Complex Interventions was used to analyze and interpret the data. Results: The uptake of the supporting components of the intervention (training and education sessions, benchmarking reports) was low. Most practices only used the CDS component of the tool, facilitated by active delivery, with general practitioners reporting acceptability and ease of use. Complexity, time, and resources were reported as barriers to the use of the auditing tool. Access to a study coordinator and ongoing practice support facilitated the sustained involvement of practices in the trial, while contextual factors, such as the COVID-19 pandemic and staff turnover, impacted their level of participation. The relevance of the intervention varied between practices, with some practices reporting very low numbers of patients who were flagged for further investigation. Conclusions: While some components of the intervention, such as the CDS tool, were considered to be acceptable and useful, this process evaluation highlighted barriers such as time and resources, practice differences, and considerations around the optimal amount of support needed when delivering the intervention. Addressing these in future studies may optimize the implementation process. Further work is needed to determine if a scaled-back approach, which meets the time and resource availability of a busy general practice, can effectively facilitate the implementation of CDS tools. Given the variation seen between practices, the use of the FHT cancer module may be better targeted to certain practices based on size, location, and patient demographics.

21 December 2023 in JMIR Preprints
Verified
Preprint
Open access
CMCaroline McBride
Caroline McBride
BHBarbara Hunter
Barbara Hunter
NLNatalie Lumsden
Natalie Lumsden
KSKaleswari Somasundaram
Kaleswari Somasundaram
RMRita McMorrow
Rita McMorrow
JMJo-Anne Manski-Nankervis
Jo-Anne Manski-Nankervis
BACKGROUND Future Health Today (FHT) is a technology program that integrates with general practice (GP) clinical software to provide point of care (PoC) clinical decision support and a quality improvement dashboard. This qualitative study looks at the use of FHT in the context of cardiovascular disease risk in chronic kidney disease (CKD). OBJECTIVE To explore factors influencing clinical implementation of the FHT module focusing on cardiovascular risk in CKD, from the perspectives of participating GP staff. METHODS Practices in Victoria were recruited to participate in a pragmatic cluster randomised control trial using FHT, of which 19 practices were randomly assigned to use FHT’s cardiovascular risk in CKD program. 13 semi-structured interviews were undertaken with a nominated GP (n =7) or practice nurse (n=6) from 10 participating practices. Interview questions focused on clinical usefulness of the tool and its place in clinical workflows. Qualitative data were coded by two researchers and analysed using Framework Analysis and Clinical Performance Feedback Intervention Theory (CP-FIT). RESULTS All 13 interviewees had used the FHT point of care tool, and feedback was largely positive. Overall, clinicians described engaging with the tool as a ‘prompt’ or ‘reminder’ system. Themes reflected that the tool’s goals and clinical content were aligned with clinician’s existing priorities and knowledge, and the tool’s design facilitated easy integration into existing workflows. The main barrier to implementation identified by two clinicians was notification fatigue. 7 interviewees had used the FHT dashboard tool. The main barriers to use were its limited integration into clinical workflows such that some participants did not know of its existence, and clinicians’ competing clinical priorities and limited time to learn and use the tool. CONCLUSIONS This study identified many facilitators for successful use of the FHT point of care program in the context of cardiovascular risk in CKD, and barriers to use of the dashboard program. This work will be used to inform wider implementation of FHT, as well as development of future modules of FHT for other risk or disease states. CLINICALTRIAL Australian New Zealand Clinical Trial Registry ACTRN12620000993998

17 June 2025 in JMIR Preprints
Verified
Preprint
Open access
JGJaviera Martinez Gutierrez
Javiera Martinez Gutierrez
KSKaleswari Somasundaram
Kaleswari Somasundaram
CBChristina Maresch Bernardes
Christina Maresch Bernardes
MRMeena Rafiq
Meena Rafiq
SSSilja Schrader
Silja Schrader
JEJon Emery
Jon Emery
BACKGROUND Early detection in primary care could improve pancreatic cancer survival, but diagnosis is often delayed due to the low prevalence of the disease, the nonspecific nature of early symptoms, and the broad range of conditions and volume of consultations managed by general practitioners (GPs). In Australia, improving pancreatic cancer outcomes, including via earlier diagnosis, is a priority being progressed under the National Pancreatic Cancer Roadmap developed by Cancer Australia. Computerized clinical decision support systems (CDSSs) have shown promise in aiding timely cancer diagnosis; however, barriers to adopting CDSS such as mistrust of the recommendations or not being embedded in the clinical workflow remain. Simulation techniques, which offer flexible and cost-effective ways to evaluate digital health interventions, can be used to test CDSS before real-world implementation. OBJECTIVE This study aims to assess the acceptability and feasibility of identifying patients with symptoms associated with pancreatic cancer through a CDSS within a simulated environment. METHODS We developed a CDSS that interacted with an electronic health record used in general practice to identify patients with symptoms, which may indicate pancreatic cancer (unintended weight loss or new-onset diabetes), in a simulation laboratory for digital interventions. We tested it by inviting GPs (n=11) to use the CDSS, with patient actors simulating specific clinical scenarios. We then interviewed GPs about the interaction to assess the acceptability and feasibility of the CDSS in their clinical practice. We used thematic analysis and 2 relevant frameworks to analyze the data. RESULTS GPs found the CDSS easy to use, unobstructive, and effective as a prompt to consider investigations for people with risk factors for pancreatic cancer. However, they expressed concerns about possible overtesting, financial costs, and the potential for anxiety in patients with a very low probability of having cancer. CONCLUSIONS While GPs found the tool useful and compatible with their workflow, concerns about overtesting, lack of evidence, and cost-effectiveness were identified as barriers. GPs favored a stepwise approach to investigations rather than immediate imaging. Despite the overall acceptability of the tool, additional evidence to underpin clinical recommendations is necessary before implementing a CDSS with these specific recommendations for pancreatic cancer in primary care.

22 October 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
RCRon Cheah
Ron Cheah
KSKaleswari Somasundaram
Kaleswari Somasundaram
KTKarin Thursky
Karin Thursky
KBKirsty Buising
Kirsty Buising
MSMatthew Suen
Matthew Suen
Ruby BiezenRuby Biezen
Ruby Biezen
Background/Objectives: Antimicrobials are regularly prescribed in general practice, yet the infrastructure to support routine review of prescribing in this setting remains limited. Integrated antimicrobial stewardship (AMS) interventions combining automated auditing of routine prescribing data with an educational component are a promising approach to addressing this gap. This qualitative study aimed to explore general practitioner (GP) and practice manager (PM) perspectives on the acceptability, feasibility, and perceived effectiveness of such an intervention implemented across 31 general practices and 97 GPs in Victoria, Australia. It also explored implementation considerations relevant to future scaling of the intervention. This is one of the first studies of GP and PM perspectives on this type of integrated program. Methods: Semi-structured interviews were conducted with 17 GPs and 5 PMs and analyzed using both inductive and deductive thematic analysis. The Theoretical Domains Framework (TDF) informed interview guide development and deductive coding; themes were generated inductively and final themes mapped to the Capability, Opportunity, Motivation–Behavior (COM-B) model for presentation. Results: Four themes were identified: (1) trust, validity, and value of audit and feedback; (2) clinical judgement and patient factors in prescribing complexity; (3) social, organizational, and professional contexts of learning and behavior change; and (4) effort, usability, and workflow in engagement with the intervention. Conclusions: Participants valued AMS activities that supported reflective practice without undermining professional autonomy. Trust in the systems managing prescribing data was a precondition for engagement with the data itself. Engagement also depended on fit with existing workflows, individualized reporting, and contextualized feedback. The social conditions under which learning occurred, such as peer interaction, moderated discussion, and collaborative reflection, mattered as much as the technical components of a program.